nodes	percent_of_prediction	percent_of_DWPC	metapath
Vardenafil—PDE5A—coronary artery disease	0.416	1	CbGaD
Vardenafil—CYP3A5—Clopidogrel—coronary artery disease	0.0288	0.103	CbGbCtD
Vardenafil—CYP3A5—Eplerenone—coronary artery disease	0.0268	0.096	CbGbCtD
Vardenafil—CYP3A5—Rosuvastatin—coronary artery disease	0.0186	0.0666	CbGbCtD
Vardenafil—CYP3A4—Ticagrelor—coronary artery disease	0.0182	0.0652	CbGbCtD
Vardenafil—CYP3A5—Simvastatin—coronary artery disease	0.0173	0.0619	CbGbCtD
Vardenafil—CYP3A5—Lovastatin—coronary artery disease	0.0169	0.0606	CbGbCtD
Vardenafil—CYP3A5—Pravastatin—coronary artery disease	0.0169	0.0606	CbGbCtD
Vardenafil—CYP3A4—Fenofibrate—coronary artery disease	0.0162	0.0581	CbGbCtD
Vardenafil—CYP3A5—Atorvastatin—coronary artery disease	0.0154	0.0552	CbGbCtD
Vardenafil—CYP3A5—Losartan—coronary artery disease	0.0141	0.0505	CbGbCtD
Vardenafil—CYP3A4—Gemfibrozil—coronary artery disease	0.013	0.0465	CbGbCtD
Vardenafil—CYP3A4—Clopidogrel—coronary artery disease	0.0112	0.0403	CbGbCtD
Vardenafil—CYP3A4—Eplerenone—coronary artery disease	0.0104	0.0375	CbGbCtD
Vardenafil—CYP3A4—Enalapril—coronary artery disease	0.0093	0.0334	CbGbCtD
Vardenafil—CYP3A4—Rosuvastatin—coronary artery disease	0.00724	0.026	CbGbCtD
Vardenafil—CYP3A4—Ezetimibe—coronary artery disease	0.00724	0.026	CbGbCtD
Vardenafil—CYP3A4—Simvastatin—coronary artery disease	0.00673	0.0241	CbGbCtD
Vardenafil—CYP3A4—Lovastatin—coronary artery disease	0.00658	0.0236	CbGbCtD
Vardenafil—CYP3A4—Pravastatin—coronary artery disease	0.00658	0.0236	CbGbCtD
Vardenafil—CYP3A4—Atorvastatin—coronary artery disease	0.006	0.0215	CbGbCtD
Vardenafil—PDE5A—pulmonary artery—coronary artery disease	0.00551	0.296	CbGeAlD
Vardenafil—CYP3A4—Losartan—coronary artery disease	0.00548	0.0197	CbGbCtD
Vardenafil—Udenafil—PDE5A—coronary artery disease	0.00266	0.617	CrCbGaD
Vardenafil—PDE5A—artery—coronary artery disease	0.00204	0.11	CbGeAlD
Vardenafil—PDE11A—heart—coronary artery disease	0.00198	0.106	CbGeAlD
Vardenafil—PDE5A—endothelium—coronary artery disease	0.00173	0.0927	CbGeAlD
Vardenafil—PDE6G—blood—coronary artery disease	0.00142	0.0763	CbGeAlD
Vardenafil—Sildenafil—PDE5A—coronary artery disease	0.00133	0.308	CrCbGaD
Vardenafil—PDE10A—heart—coronary artery disease	0.00129	0.069	CbGeAlD
Vardenafil—PDE1B—heart—coronary artery disease	0.00127	0.0684	CbGeAlD
Vardenafil—PDE1B—blood—coronary artery disease	0.000951	0.0511	CbGeAlD
Vardenafil—PDE5A—heart—coronary artery disease	0.000752	0.0404	CbGeAlD
Vardenafil—PDE5A—cardiovascular system—coronary artery disease	0.00071	0.0381	CbGeAlD
Vardenafil—PDE5A—blood—coronary artery disease	0.000562	0.0301	CbGeAlD
Vardenafil—Sildenafil—CYP2C19—coronary artery disease	0.000321	0.0747	CrCbGaD
Vardenafil—CYP3A5—blood—coronary artery disease	0.000233	0.0125	CbGeAlD
Vardenafil—CYP3A4—blood—coronary artery disease	0.000175	0.0094	CbGeAlD
Vardenafil—Unspecified disorder of skin and subcutaneous tissue—Ramipril—coronary artery disease	5.75e-05	0.000342	CcSEcCtD
Vardenafil—Dermatitis—Clopidogrel—coronary artery disease	5.74e-05	0.000342	CcSEcCtD
Vardenafil—Asthenia—Valsartan—coronary artery disease	5.74e-05	0.000342	CcSEcCtD
Vardenafil—Pain—Furosemide—coronary artery disease	5.73e-05	0.000342	CcSEcCtD
Vardenafil—Hypersensitivity—Niacin—coronary artery disease	5.73e-05	0.000341	CcSEcCtD
Vardenafil—Ill-defined disorder—Lisinopril—coronary artery disease	5.72e-05	0.000341	CcSEcCtD
Vardenafil—Discomfort—Ramipril—coronary artery disease	5.72e-05	0.000341	CcSEcCtD
Vardenafil—Asthenia—Olmesartan—coronary artery disease	5.71e-05	0.00034	CcSEcCtD
Vardenafil—Headache—Clopidogrel—coronary artery disease	5.71e-05	0.00034	CcSEcCtD
Vardenafil—Rash—Lovastatin—coronary artery disease	5.71e-05	0.00034	CcSEcCtD
Vardenafil—Dermatitis—Lovastatin—coronary artery disease	5.7e-05	0.00034	CcSEcCtD
Vardenafil—Dyspepsia—Losartan—coronary artery disease	5.69e-05	0.000339	CcSEcCtD
Vardenafil—Feeling abnormal—Perindopril—coronary artery disease	5.68e-05	0.000339	CcSEcCtD
Vardenafil—Headache—Lovastatin—coronary artery disease	5.67e-05	0.000338	CcSEcCtD
Vardenafil—Pruritus—Valsartan—coronary artery disease	5.66e-05	0.000337	CcSEcCtD
Vardenafil—Dry mouth—Ramipril—coronary artery disease	5.66e-05	0.000337	CcSEcCtD
Vardenafil—Myalgia—Timolol—coronary artery disease	5.66e-05	0.000337	CcSEcCtD
Vardenafil—Chest pain—Timolol—coronary artery disease	5.66e-05	0.000337	CcSEcCtD
Vardenafil—Arthralgia—Timolol—coronary artery disease	5.66e-05	0.000337	CcSEcCtD
Vardenafil—Vomiting—Ezetimibe—coronary artery disease	5.65e-05	0.000336	CcSEcCtD
Vardenafil—Hypersensitivity—Pravastatin—coronary artery disease	5.64e-05	0.000336	CcSEcCtD
Vardenafil—Gastrointestinal pain—Perindopril—coronary artery disease	5.64e-05	0.000336	CcSEcCtD
Vardenafil—Anxiety—Timolol—coronary artery disease	5.64e-05	0.000336	CcSEcCtD
Vardenafil—Angioedema—Lisinopril—coronary artery disease	5.63e-05	0.000335	CcSEcCtD
Vardenafil—Pruritus—Olmesartan—coronary artery disease	5.63e-05	0.000335	CcSEcCtD
Vardenafil—Unspecified disorder of skin and subcutaneous tissue—Timolol—coronary artery disease	5.62e-05	0.000335	CcSEcCtD
Vardenafil—Abdominal pain—Captopril—coronary artery disease	5.62e-05	0.000334	CcSEcCtD
Vardenafil—Dizziness—Simvastatin—coronary artery disease	5.6e-05	0.000334	CcSEcCtD
Vardenafil—Rash—Ezetimibe—coronary artery disease	5.6e-05	0.000334	CcSEcCtD
Vardenafil—Dermatitis—Ezetimibe—coronary artery disease	5.59e-05	0.000333	CcSEcCtD
Vardenafil—Discomfort—Timolol—coronary artery disease	5.59e-05	0.000333	CcSEcCtD
Vardenafil—Asthenia—Niacin—coronary artery disease	5.58e-05	0.000332	CcSEcCtD
Vardenafil—Headache—Ezetimibe—coronary artery disease	5.56e-05	0.000331	CcSEcCtD
Vardenafil—Malaise—Lisinopril—coronary artery disease	5.56e-05	0.000331	CcSEcCtD
Vardenafil—Anaphylactic shock—Ramipril—coronary artery disease	5.55e-05	0.00033	CcSEcCtD
Vardenafil—Vertigo—Lisinopril—coronary artery disease	5.54e-05	0.00033	CcSEcCtD
Vardenafil—Dry mouth—Timolol—coronary artery disease	5.53e-05	0.00033	CcSEcCtD
Vardenafil—Pain—Losartan—coronary artery disease	5.53e-05	0.00033	CcSEcCtD
Vardenafil—Syncope—Lisinopril—coronary artery disease	5.53e-05	0.000329	CcSEcCtD
Vardenafil—Vomiting—Eplerenone—coronary artery disease	5.53e-05	0.000329	CcSEcCtD
Vardenafil—Feeling abnormal—Furosemide—coronary artery disease	5.52e-05	0.000329	CcSEcCtD
Vardenafil—Nausea—Fenofibrate—coronary artery disease	5.51e-05	0.000328	CcSEcCtD
Vardenafil—Pruritus—Niacin—coronary artery disease	5.5e-05	0.000328	CcSEcCtD
Vardenafil—Asthenia—Pravastatin—coronary artery disease	5.49e-05	0.000327	CcSEcCtD
Vardenafil—Gastrointestinal pain—Furosemide—coronary artery disease	5.48e-05	0.000327	CcSEcCtD
Vardenafil—Rash—Eplerenone—coronary artery disease	5.48e-05	0.000326	CcSEcCtD
Vardenafil—Hypersensitivity—Trandolapril—coronary artery disease	5.48e-05	0.000326	CcSEcCtD
Vardenafil—Dermatitis—Eplerenone—coronary artery disease	5.48e-05	0.000326	CcSEcCtD
Vardenafil—Diarrhoea—Valsartan—coronary artery disease	5.47e-05	0.000326	CcSEcCtD
Vardenafil—Shock—Ramipril—coronary artery disease	5.46e-05	0.000325	CcSEcCtD
Vardenafil—Hypersensitivity—Enalapril—coronary artery disease	5.46e-05	0.000325	CcSEcCtD
Vardenafil—Abdominal pain—Perindopril—coronary artery disease	5.45e-05	0.000325	CcSEcCtD
Vardenafil—Palpitations—Lisinopril—coronary artery disease	5.45e-05	0.000324	CcSEcCtD
Vardenafil—Diarrhoea—Olmesartan—coronary artery disease	5.45e-05	0.000324	CcSEcCtD
Vardenafil—Headache—Eplerenone—coronary artery disease	5.45e-05	0.000324	CcSEcCtD
Vardenafil—Nervous system disorder—Ramipril—coronary artery disease	5.44e-05	0.000324	CcSEcCtD
Vardenafil—Anaphylactic shock—Timolol—coronary artery disease	5.42e-05	0.000323	CcSEcCtD
Vardenafil—Pruritus—Pravastatin—coronary artery disease	5.42e-05	0.000323	CcSEcCtD
Vardenafil—Loss of consciousness—Lisinopril—coronary artery disease	5.42e-05	0.000323	CcSEcCtD
Vardenafil—Nausea—Clopidogrel—coronary artery disease	5.41e-05	0.000323	CcSEcCtD
Vardenafil—Tachycardia—Ramipril—coronary artery disease	5.41e-05	0.000322	CcSEcCtD
Vardenafil—Skin disorder—Ramipril—coronary artery disease	5.39e-05	0.000321	CcSEcCtD
Vardenafil—Infection—Timolol—coronary artery disease	5.39e-05	0.000321	CcSEcCtD
Vardenafil—Vomiting—Simvastatin—coronary artery disease	5.38e-05	0.000321	CcSEcCtD
Vardenafil—Hypersensitivity—Telmisartan—coronary artery disease	5.38e-05	0.000321	CcSEcCtD
Vardenafil—Nausea—Lovastatin—coronary artery disease	5.38e-05	0.00032	CcSEcCtD
Vardenafil—Hyperhidrosis—Ramipril—coronary artery disease	5.36e-05	0.000319	CcSEcCtD
Vardenafil—Rash—Simvastatin—coronary artery disease	5.34e-05	0.000318	CcSEcCtD
Vardenafil—Dermatitis—Simvastatin—coronary artery disease	5.34e-05	0.000318	CcSEcCtD
Vardenafil—Asthenia—Trandolapril—coronary artery disease	5.33e-05	0.000318	CcSEcCtD
Vardenafil—Shock—Timolol—coronary artery disease	5.33e-05	0.000318	CcSEcCtD
Vardenafil—Feeling abnormal—Losartan—coronary artery disease	5.33e-05	0.000318	CcSEcCtD
Vardenafil—Diarrhoea—Niacin—coronary artery disease	5.32e-05	0.000317	CcSEcCtD
Vardenafil—Nervous system disorder—Timolol—coronary artery disease	5.32e-05	0.000317	CcSEcCtD
Vardenafil—Asthenia—Enalapril—coronary artery disease	5.31e-05	0.000317	CcSEcCtD
Vardenafil—Headache—Simvastatin—coronary artery disease	5.31e-05	0.000316	CcSEcCtD
Vardenafil—Abdominal pain—Furosemide—coronary artery disease	5.3e-05	0.000316	CcSEcCtD
Vardenafil—Gastrointestinal pain—Losartan—coronary artery disease	5.29e-05	0.000315	CcSEcCtD
Vardenafil—Dizziness—Valsartan—coronary artery disease	5.29e-05	0.000315	CcSEcCtD
Vardenafil—Nausea—Ezetimibe—coronary artery disease	5.28e-05	0.000314	CcSEcCtD
Vardenafil—Skin disorder—Timolol—coronary artery disease	5.27e-05	0.000314	CcSEcCtD
Vardenafil—Dizziness—Olmesartan—coronary artery disease	5.26e-05	0.000314	CcSEcCtD
Vardenafil—Pruritus—Trandolapril—coronary artery disease	5.26e-05	0.000313	CcSEcCtD
Vardenafil—Arthralgia—Lisinopril—coronary artery disease	5.25e-05	0.000313	CcSEcCtD
Vardenafil—Myalgia—Lisinopril—coronary artery disease	5.25e-05	0.000313	CcSEcCtD
Vardenafil—Chest pain—Lisinopril—coronary artery disease	5.25e-05	0.000313	CcSEcCtD
Vardenafil—Hyperhidrosis—Timolol—coronary artery disease	5.24e-05	0.000312	CcSEcCtD
Vardenafil—Asthenia—Telmisartan—coronary artery disease	5.24e-05	0.000312	CcSEcCtD
Vardenafil—Pruritus—Enalapril—coronary artery disease	5.24e-05	0.000312	CcSEcCtD
Vardenafil—Diarrhoea—Pravastatin—coronary artery disease	5.24e-05	0.000312	CcSEcCtD
Vardenafil—Anxiety—Lisinopril—coronary artery disease	5.23e-05	0.000312	CcSEcCtD
Vardenafil—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—coronary artery disease	5.21e-05	0.00031	CcSEcCtD
Vardenafil—Discomfort—Lisinopril—coronary artery disease	5.18e-05	0.000309	CcSEcCtD
Vardenafil—Hypotension—Ramipril—coronary artery disease	5.18e-05	0.000309	CcSEcCtD
Vardenafil—Pruritus—Telmisartan—coronary artery disease	5.17e-05	0.000308	CcSEcCtD
Vardenafil—Nausea—Eplerenone—coronary artery disease	5.16e-05	0.000308	CcSEcCtD
Vardenafil—Dizziness—Niacin—coronary artery disease	5.14e-05	0.000306	CcSEcCtD
Vardenafil—Dry mouth—Lisinopril—coronary artery disease	5.13e-05	0.000306	CcSEcCtD
Vardenafil—Abdominal pain—Losartan—coronary artery disease	5.11e-05	0.000305	CcSEcCtD
Vardenafil—Asthenia—Captopril—coronary artery disease	5.1e-05	0.000304	CcSEcCtD
Vardenafil—Diarrhoea—Trandolapril—coronary artery disease	5.09e-05	0.000303	CcSEcCtD
Vardenafil—Vomiting—Valsartan—coronary artery disease	5.09e-05	0.000303	CcSEcCtD
Vardenafil—Diarrhoea—Enalapril—coronary artery disease	5.07e-05	0.000302	CcSEcCtD
Vardenafil—Hypotension—Timolol—coronary artery disease	5.07e-05	0.000302	CcSEcCtD
Vardenafil—Dizziness—Pravastatin—coronary artery disease	5.06e-05	0.000302	CcSEcCtD
Vardenafil—Vomiting—Olmesartan—coronary artery disease	5.06e-05	0.000301	CcSEcCtD
Vardenafil—Musculoskeletal discomfort—Ramipril—coronary artery disease	5.05e-05	0.000301	CcSEcCtD
Vardenafil—Rash—Valsartan—coronary artery disease	5.04e-05	0.0003	CcSEcCtD
Vardenafil—Dermatitis—Valsartan—coronary artery disease	5.04e-05	0.0003	CcSEcCtD
Vardenafil—Nausea—Simvastatin—coronary artery disease	5.03e-05	0.0003	CcSEcCtD
Vardenafil—Anaphylactic shock—Lisinopril—coronary artery disease	5.03e-05	0.0003	CcSEcCtD
Vardenafil—Pruritus—Captopril—coronary artery disease	5.03e-05	0.000299	CcSEcCtD
Vardenafil—Rash—Olmesartan—coronary artery disease	5.02e-05	0.000299	CcSEcCtD
Vardenafil—Insomnia—Ramipril—coronary artery disease	5.02e-05	0.000299	CcSEcCtD
Vardenafil—Dermatitis—Olmesartan—coronary artery disease	5.01e-05	0.000299	CcSEcCtD
Vardenafil—Headache—Valsartan—coronary artery disease	5.01e-05	0.000298	CcSEcCtD
Vardenafil—Diarrhoea—Telmisartan—coronary artery disease	5e-05	0.000298	CcSEcCtD
Vardenafil—Infection—Lisinopril—coronary artery disease	5e-05	0.000298	CcSEcCtD
Vardenafil—Headache—Olmesartan—coronary artery disease	4.99e-05	0.000297	CcSEcCtD
Vardenafil—Paraesthesia—Ramipril—coronary artery disease	4.98e-05	0.000297	CcSEcCtD
Vardenafil—Shock—Lisinopril—coronary artery disease	4.95e-05	0.000295	CcSEcCtD
Vardenafil—Asthenia—Perindopril—coronary artery disease	4.95e-05	0.000295	CcSEcCtD
Vardenafil—Dyspnoea—Ramipril—coronary artery disease	4.95e-05	0.000295	CcSEcCtD
Vardenafil—Vomiting—Niacin—coronary artery disease	4.94e-05	0.000295	CcSEcCtD
Vardenafil—Musculoskeletal discomfort—Timolol—coronary artery disease	4.94e-05	0.000294	CcSEcCtD
Vardenafil—Hypersensitivity—Furosemide—coronary artery disease	4.94e-05	0.000294	CcSEcCtD
Vardenafil—Somnolence—Ramipril—coronary artery disease	4.93e-05	0.000294	CcSEcCtD
Vardenafil—Dizziness—Trandolapril—coronary artery disease	4.92e-05	0.000293	CcSEcCtD
Vardenafil—Tachycardia—Lisinopril—coronary artery disease	4.91e-05	0.000292	CcSEcCtD
Vardenafil—Insomnia—Timolol—coronary artery disease	4.9e-05	0.000292	CcSEcCtD
Vardenafil—Rash—Niacin—coronary artery disease	4.9e-05	0.000292	CcSEcCtD
Vardenafil—Dermatitis—Niacin—coronary artery disease	4.9e-05	0.000292	CcSEcCtD
Vardenafil—Dizziness—Enalapril—coronary artery disease	4.9e-05	0.000292	CcSEcCtD
Vardenafil—Skin disorder—Lisinopril—coronary artery disease	4.89e-05	0.000291	CcSEcCtD
Vardenafil—Dyspepsia—Ramipril—coronary artery disease	4.88e-05	0.000291	CcSEcCtD
Vardenafil—Pruritus—Perindopril—coronary artery disease	4.88e-05	0.000291	CcSEcCtD
Vardenafil—Headache—Niacin—coronary artery disease	4.87e-05	0.00029	CcSEcCtD
Vardenafil—Paraesthesia—Timolol—coronary artery disease	4.87e-05	0.00029	CcSEcCtD
Vardenafil—Vomiting—Pravastatin—coronary artery disease	4.87e-05	0.00029	CcSEcCtD
Vardenafil—Hyperhidrosis—Lisinopril—coronary artery disease	4.86e-05	0.00029	CcSEcCtD
Vardenafil—Diarrhoea—Captopril—coronary artery disease	4.86e-05	0.00029	CcSEcCtD
Vardenafil—Dyspnoea—Timolol—coronary artery disease	4.83e-05	0.000288	CcSEcCtD
Vardenafil—Dizziness—Telmisartan—coronary artery disease	4.83e-05	0.000288	CcSEcCtD
Vardenafil—Rash—Pravastatin—coronary artery disease	4.83e-05	0.000288	CcSEcCtD
Vardenafil—Dermatitis—Pravastatin—coronary artery disease	4.82e-05	0.000287	CcSEcCtD
Vardenafil—Somnolence—Timolol—coronary artery disease	4.82e-05	0.000287	CcSEcCtD
Vardenafil—Asthenia—Furosemide—coronary artery disease	4.81e-05	0.000287	CcSEcCtD
Vardenafil—Headache—Pravastatin—coronary artery disease	4.8e-05	0.000286	CcSEcCtD
Vardenafil—Gastrointestinal disorder—Ramipril—coronary artery disease	4.79e-05	0.000285	CcSEcCtD
Vardenafil—Dyspepsia—Timolol—coronary artery disease	4.77e-05	0.000284	CcSEcCtD
Vardenafil—Hypersensitivity—Losartan—coronary artery disease	4.77e-05	0.000284	CcSEcCtD
Vardenafil—Nausea—Valsartan—coronary artery disease	4.75e-05	0.000283	CcSEcCtD
Vardenafil—Pruritus—Furosemide—coronary artery disease	4.74e-05	0.000283	CcSEcCtD
Vardenafil—Nausea—Olmesartan—coronary artery disease	4.73e-05	0.000282	CcSEcCtD
Vardenafil—Vomiting—Trandolapril—coronary artery disease	4.73e-05	0.000282	CcSEcCtD
Vardenafil—Diarrhoea—Perindopril—coronary artery disease	4.72e-05	0.000281	CcSEcCtD
Vardenafil—Vomiting—Enalapril—coronary artery disease	4.71e-05	0.00028	CcSEcCtD
Vardenafil—Hypotension—Lisinopril—coronary artery disease	4.7e-05	0.00028	CcSEcCtD
Vardenafil—Dizziness—Captopril—coronary artery disease	4.7e-05	0.00028	CcSEcCtD
Vardenafil—Rash—Trandolapril—coronary artery disease	4.69e-05	0.000279	CcSEcCtD
Vardenafil—Dermatitis—Trandolapril—coronary artery disease	4.68e-05	0.000279	CcSEcCtD
Vardenafil—Gastrointestinal disorder—Timolol—coronary artery disease	4.68e-05	0.000279	CcSEcCtD
Vardenafil—Rash—Enalapril—coronary artery disease	4.67e-05	0.000278	CcSEcCtD
Vardenafil—Dermatitis—Enalapril—coronary artery disease	4.67e-05	0.000278	CcSEcCtD
Vardenafil—Headache—Trandolapril—coronary artery disease	4.66e-05	0.000277	CcSEcCtD
Vardenafil—Vomiting—Telmisartan—coronary artery disease	4.64e-05	0.000277	CcSEcCtD
Vardenafil—Asthenia—Losartan—coronary artery disease	4.64e-05	0.000276	CcSEcCtD
Vardenafil—Headache—Enalapril—coronary artery disease	4.64e-05	0.000276	CcSEcCtD
Vardenafil—Pain—Timolol—coronary artery disease	4.64e-05	0.000276	CcSEcCtD
Vardenafil—Nausea—Niacin—coronary artery disease	4.62e-05	0.000275	CcSEcCtD
Vardenafil—Rash—Telmisartan—coronary artery disease	4.61e-05	0.000274	CcSEcCtD
Vardenafil—Dermatitis—Telmisartan—coronary artery disease	4.6e-05	0.000274	CcSEcCtD
Vardenafil—Diarrhoea—Furosemide—coronary artery disease	4.59e-05	0.000273	CcSEcCtD
Vardenafil—Musculoskeletal discomfort—Lisinopril—coronary artery disease	4.58e-05	0.000273	CcSEcCtD
Vardenafil—Pruritus—Losartan—coronary artery disease	4.58e-05	0.000273	CcSEcCtD
Vardenafil—Headache—Telmisartan—coronary artery disease	4.58e-05	0.000273	CcSEcCtD
Vardenafil—Feeling abnormal—Ramipril—coronary artery disease	4.57e-05	0.000272	CcSEcCtD
Vardenafil—Dizziness—Perindopril—coronary artery disease	4.56e-05	0.000272	CcSEcCtD
Vardenafil—Insomnia—Lisinopril—coronary artery disease	4.55e-05	0.000271	CcSEcCtD
Vardenafil—Nausea—Pravastatin—coronary artery disease	4.55e-05	0.000271	CcSEcCtD
Vardenafil—Gastrointestinal pain—Ramipril—coronary artery disease	4.54e-05	0.00027	CcSEcCtD
Vardenafil—Paraesthesia—Lisinopril—coronary artery disease	4.52e-05	0.000269	CcSEcCtD
Vardenafil—Vomiting—Captopril—coronary artery disease	4.52e-05	0.000269	CcSEcCtD
Vardenafil—Dyspnoea—Lisinopril—coronary artery disease	4.48e-05	0.000267	CcSEcCtD
Vardenafil—Rash—Captopril—coronary artery disease	4.48e-05	0.000267	CcSEcCtD
Vardenafil—Dermatitis—Captopril—coronary artery disease	4.47e-05	0.000267	CcSEcCtD
Vardenafil—Somnolence—Lisinopril—coronary artery disease	4.47e-05	0.000266	CcSEcCtD
Vardenafil—Feeling abnormal—Timolol—coronary artery disease	4.47e-05	0.000266	CcSEcCtD
Vardenafil—Headache—Captopril—coronary artery disease	4.45e-05	0.000265	CcSEcCtD
Vardenafil—Gastrointestinal pain—Timolol—coronary artery disease	4.43e-05	0.000264	CcSEcCtD
Vardenafil—Dizziness—Furosemide—coronary artery disease	4.43e-05	0.000264	CcSEcCtD
Vardenafil—Dyspepsia—Lisinopril—coronary artery disease	4.43e-05	0.000264	CcSEcCtD
Vardenafil—Diarrhoea—Losartan—coronary artery disease	4.43e-05	0.000264	CcSEcCtD
Vardenafil—Nausea—Trandolapril—coronary artery disease	4.42e-05	0.000263	CcSEcCtD
Vardenafil—Nausea—Enalapril—coronary artery disease	4.4e-05	0.000262	CcSEcCtD
Vardenafil—Vomiting—Perindopril—coronary artery disease	4.38e-05	0.000261	CcSEcCtD
Vardenafil—Abdominal pain—Ramipril—coronary artery disease	4.38e-05	0.000261	CcSEcCtD
Vardenafil—Rash—Perindopril—coronary artery disease	4.35e-05	0.000259	CcSEcCtD
Vardenafil—Dermatitis—Perindopril—coronary artery disease	4.34e-05	0.000259	CcSEcCtD
Vardenafil—Gastrointestinal disorder—Lisinopril—coronary artery disease	4.34e-05	0.000259	CcSEcCtD
Vardenafil—Nausea—Telmisartan—coronary artery disease	4.34e-05	0.000258	CcSEcCtD
Vardenafil—Headache—Perindopril—coronary artery disease	4.32e-05	0.000257	CcSEcCtD
Vardenafil—Pain—Lisinopril—coronary artery disease	4.3e-05	0.000256	CcSEcCtD
Vardenafil—Abdominal pain—Timolol—coronary artery disease	4.29e-05	0.000255	CcSEcCtD
Vardenafil—Dizziness—Losartan—coronary artery disease	4.28e-05	0.000255	CcSEcCtD
Vardenafil—Vomiting—Furosemide—coronary artery disease	4.26e-05	0.000254	CcSEcCtD
Vardenafil—Rash—Furosemide—coronary artery disease	4.23e-05	0.000252	CcSEcCtD
Vardenafil—Dermatitis—Furosemide—coronary artery disease	4.22e-05	0.000252	CcSEcCtD
Vardenafil—Nausea—Captopril—coronary artery disease	4.22e-05	0.000251	CcSEcCtD
Vardenafil—Headache—Furosemide—coronary artery disease	4.2e-05	0.00025	CcSEcCtD
Vardenafil—Feeling abnormal—Lisinopril—coronary artery disease	4.15e-05	0.000247	CcSEcCtD
Vardenafil—Gastrointestinal pain—Lisinopril—coronary artery disease	4.11e-05	0.000245	CcSEcCtD
Vardenafil—Vomiting—Losartan—coronary artery disease	4.11e-05	0.000245	CcSEcCtD
Vardenafil—Nausea—Perindopril—coronary artery disease	4.1e-05	0.000244	CcSEcCtD
Vardenafil—Hypersensitivity—Ramipril—coronary artery disease	4.09e-05	0.000243	CcSEcCtD
Vardenafil—Rash—Losartan—coronary artery disease	4.08e-05	0.000243	CcSEcCtD
Vardenafil—Dermatitis—Losartan—coronary artery disease	4.07e-05	0.000243	CcSEcCtD
Vardenafil—Headache—Losartan—coronary artery disease	4.05e-05	0.000241	CcSEcCtD
Vardenafil—Hypersensitivity—Timolol—coronary artery disease	4e-05	0.000238	CcSEcCtD
Vardenafil—Nausea—Furosemide—coronary artery disease	3.98e-05	0.000237	CcSEcCtD
Vardenafil—Asthenia—Ramipril—coronary artery disease	3.98e-05	0.000237	CcSEcCtD
Vardenafil—Abdominal pain—Lisinopril—coronary artery disease	3.98e-05	0.000237	CcSEcCtD
Vardenafil—Pruritus—Ramipril—coronary artery disease	3.92e-05	0.000234	CcSEcCtD
Vardenafil—Asthenia—Timolol—coronary artery disease	3.89e-05	0.000232	CcSEcCtD
Vardenafil—Nausea—Losartan—coronary artery disease	3.84e-05	0.000229	CcSEcCtD
Vardenafil—Pruritus—Timolol—coronary artery disease	3.84e-05	0.000229	CcSEcCtD
Vardenafil—Diarrhoea—Ramipril—coronary artery disease	3.8e-05	0.000226	CcSEcCtD
Vardenafil—Diarrhoea—Timolol—coronary artery disease	3.71e-05	0.000221	CcSEcCtD
Vardenafil—Hypersensitivity—Lisinopril—coronary artery disease	3.71e-05	0.000221	CcSEcCtD
Vardenafil—Dizziness—Ramipril—coronary artery disease	3.67e-05	0.000218	CcSEcCtD
Vardenafil—Asthenia—Lisinopril—coronary artery disease	3.61e-05	0.000215	CcSEcCtD
Vardenafil—Dizziness—Timolol—coronary artery disease	3.59e-05	0.000214	CcSEcCtD
Vardenafil—Pruritus—Lisinopril—coronary artery disease	3.56e-05	0.000212	CcSEcCtD
Vardenafil—Vomiting—Ramipril—coronary artery disease	3.53e-05	0.00021	CcSEcCtD
Vardenafil—Rash—Ramipril—coronary artery disease	3.5e-05	0.000208	CcSEcCtD
Vardenafil—Dermatitis—Ramipril—coronary artery disease	3.49e-05	0.000208	CcSEcCtD
Vardenafil—Headache—Ramipril—coronary artery disease	3.47e-05	0.000207	CcSEcCtD
Vardenafil—Vomiting—Timolol—coronary artery disease	3.45e-05	0.000205	CcSEcCtD
Vardenafil—Diarrhoea—Lisinopril—coronary artery disease	3.44e-05	0.000205	CcSEcCtD
Vardenafil—Rash—Timolol—coronary artery disease	3.42e-05	0.000204	CcSEcCtD
Vardenafil—Dermatitis—Timolol—coronary artery disease	3.42e-05	0.000203	CcSEcCtD
Vardenafil—Headache—Timolol—coronary artery disease	3.4e-05	0.000202	CcSEcCtD
Vardenafil—Dizziness—Lisinopril—coronary artery disease	3.33e-05	0.000198	CcSEcCtD
Vardenafil—Nausea—Ramipril—coronary artery disease	3.29e-05	0.000196	CcSEcCtD
Vardenafil—Nausea—Timolol—coronary artery disease	3.22e-05	0.000192	CcSEcCtD
Vardenafil—Vomiting—Lisinopril—coronary artery disease	3.2e-05	0.000191	CcSEcCtD
Vardenafil—Rash—Lisinopril—coronary artery disease	3.17e-05	0.000189	CcSEcCtD
Vardenafil—Dermatitis—Lisinopril—coronary artery disease	3.17e-05	0.000189	CcSEcCtD
Vardenafil—Headache—Lisinopril—coronary artery disease	3.15e-05	0.000188	CcSEcCtD
Vardenafil—Nausea—Lisinopril—coronary artery disease	2.99e-05	0.000178	CcSEcCtD
Vardenafil—CYP3A5—Metabolism—HK1—coronary artery disease	6.21e-06	5.44e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—CSF2—coronary artery disease	6.15e-06	5.39e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—FGF1—coronary artery disease	6.15e-06	5.39e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—PPAP2B—coronary artery disease	6.14e-06	5.38e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—UQCRFS1—coronary artery disease	6.14e-06	5.38e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—CKM—coronary artery disease	6.14e-06	5.38e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—HADHA—coronary artery disease	6.14e-06	5.37e-05	CbGpPWpGaD
Vardenafil—PDE1B—Disease—IL6R—coronary artery disease	6.12e-06	5.36e-05	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—VEGFA—coronary artery disease	6.11e-06	5.36e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—LPL—coronary artery disease	6.1e-06	5.35e-05	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—MMP9—coronary artery disease	6.07e-06	5.32e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—GSTA1—coronary artery disease	6.06e-06	5.31e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—RPS6KB1—coronary artery disease	6.05e-06	5.3e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—MEF2C—coronary artery disease	6.05e-06	5.3e-05	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—FGF2—coronary artery disease	6.01e-06	5.27e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—LPA—coronary artery disease	6e-06	5.25e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—ITGB3—coronary artery disease	5.9e-06	5.16e-05	CbGpPWpGaD
Vardenafil—PDE10A—Signaling by GPCR—AKT1—coronary artery disease	5.89e-06	5.16e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—PLCB3—coronary artery disease	5.81e-06	5.09e-05	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—JAK2—coronary artery disease	5.76e-06	5.05e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—CXCL8—coronary artery disease	5.76e-06	5.04e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—APOA5—coronary artery disease	5.75e-06	5.04e-05	CbGpPWpGaD
Vardenafil—PDE1B—Disease—SERPINE1—coronary artery disease	5.73e-06	5.02e-05	CbGpPWpGaD
Vardenafil—PDE1B—Innate Immune System—PIK3CA—coronary artery disease	5.73e-06	5.02e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—PPP2CA—coronary artery disease	5.73e-06	5.02e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—PYGM—coronary artery disease	5.71e-06	5e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—ALDH6A1—coronary artery disease	5.71e-06	5e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—SULT4A1—coronary artery disease	5.71e-06	5e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—PDK4—coronary artery disease	5.71e-06	5e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—CKMT2—coronary artery disease	5.71e-06	5e-05	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—BCL2—coronary artery disease	5.71e-06	5e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Biological oxidations—POMC—coronary artery disease	5.69e-06	4.98e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—P4HB—coronary artery disease	5.64e-06	4.94e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—PRKCD—coronary artery disease	5.62e-06	4.93e-05	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—TGFB1—coronary artery disease	5.61e-06	4.92e-05	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—VEGFA—coronary artery disease	5.59e-06	4.9e-05	CbGpPWpGaD
Vardenafil—PDE1B—Disease—FGF2—coronary artery disease	5.55e-06	4.86e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—PLA2G1B—coronary artery disease	5.53e-06	4.85e-05	CbGpPWpGaD
Vardenafil—PDE6G—Disease—IL6—coronary artery disease	5.52e-06	4.84e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—HTR2A—coronary artery disease	5.5e-06	4.82e-05	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—MAPK1—coronary artery disease	5.5e-06	4.82e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—C3—coronary artery disease	5.5e-06	4.81e-05	CbGpPWpGaD
Vardenafil—PDE1B—Disease—NOS3—coronary artery disease	5.47e-06	4.79e-05	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—VEGFA—coronary artery disease	5.45e-06	4.77e-05	CbGpPWpGaD
Vardenafil—PDE1B—Disease—JAK2—coronary artery disease	5.32e-06	4.66e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—HIF1A—coronary artery disease	5.24e-06	4.59e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—AGT—coronary artery disease	5.22e-06	4.57e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—VCAN—coronary artery disease	5.22e-06	4.57e-05	CbGpPWpGaD
Vardenafil—PDE1B—Hemostasis—AKT1—coronary artery disease	5.2e-06	4.55e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—ALDOA—coronary artery disease	5.18e-06	4.53e-05	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—TGFB1—coronary artery disease	5.13e-06	4.5e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—LEP—coronary artery disease	5.12e-06	4.48e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—APOE—coronary artery disease	5.12e-06	4.48e-05	CbGpPWpGaD
Vardenafil—PDE6G—Disease—AKT1—coronary artery disease	5.09e-06	4.46e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—GYG1—coronary artery disease	5.09e-06	4.46e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—PFKM—coronary artery disease	5.09e-06	4.46e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—LDHA—coronary artery disease	5.09e-06	4.46e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—HMGCS2—coronary artery disease	5.09e-06	4.46e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—GK—coronary artery disease	5.09e-06	4.46e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—GATM—coronary artery disease	5.09e-06	4.46e-05	CbGpPWpGaD
Vardenafil—PDE1B—Innate Immune System—IL6—coronary artery disease	5.07e-06	4.44e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—APOA1—coronary artery disease	5.06e-06	4.43e-05	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—IL1B—coronary artery disease	5.05e-06	4.42e-05	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—MAPK1—coronary artery disease	5.03e-06	4.41e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—DCN—coronary artery disease	5.03e-06	4.4e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—KDR—coronary artery disease	5.01e-06	4.39e-05	CbGpPWpGaD
Vardenafil—PDE1B—Disease—PTGS2—coronary artery disease	5.01e-06	4.39e-05	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—TGFB1—coronary artery disease	5e-06	4.38e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—MAPK14—coronary artery disease	4.98e-06	4.36e-05	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—MAPK1—coronary artery disease	4.9e-06	4.3e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—ALDH2—coronary artery disease	4.89e-06	4.28e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—ESR1—coronary artery disease	4.89e-06	4.28e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—AK1—coronary artery disease	4.85e-06	4.25e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—GCH1—coronary artery disease	4.85e-06	4.25e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—F2—coronary artery disease	4.83e-06	4.23e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—FN1—coronary artery disease	4.83e-06	4.23e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—IL6ST—coronary artery disease	4.81e-06	4.21e-05	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—PIK3CA—coronary artery disease	4.78e-06	4.18e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—NFKBIA—coronary artery disease	4.77e-06	4.18e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—LIPC—coronary artery disease	4.76e-06	4.17e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—HBA1—coronary artery disease	4.76e-06	4.17e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—PIK3C2A—coronary artery disease	4.76e-06	4.17e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—CYP2C19—coronary artery disease	4.76e-06	4.17e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—APOC3—coronary artery disease	4.73e-06	4.15e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—LDLR—coronary artery disease	4.71e-06	4.12e-05	CbGpPWpGaD
Vardenafil—PDE1B—Innate Immune System—AKT1—coronary artery disease	4.68e-06	4.1e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—PPAT—coronary artery disease	4.65e-06	4.08e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—MDH2—coronary artery disease	4.65e-06	4.08e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—UGCG—coronary artery disease	4.65e-06	4.08e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—PLCD1—coronary artery disease	4.65e-06	4.08e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—GSTT1—coronary artery disease	4.65e-06	4.07e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—SLC9A1—coronary artery disease	4.65e-06	4.07e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—KIT—coronary artery disease	4.62e-06	4.04e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—GCLC—coronary artery disease	4.6e-06	4.03e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—CETP—coronary artery disease	4.6e-06	4.03e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—SDC1—coronary artery disease	4.54e-06	3.98e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—PGM1—coronary artery disease	4.48e-06	3.92e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—GSK3B—coronary artery disease	4.43e-06	3.88e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—POMC—coronary artery disease	4.4e-06	3.85e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—CREB1—coronary artery disease	4.4e-06	3.85e-05	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—PIK3CA—coronary artery disease	4.37e-06	3.83e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—PYGB—coronary artery disease	4.33e-06	3.79e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—CKB—coronary artery disease	4.33e-06	3.79e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—CCL2—coronary artery disease	4.3e-06	3.77e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—PSMB5—coronary artery disease	4.29e-06	3.76e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—PSMA6—coronary artery disease	4.29e-06	3.76e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—IL6R—coronary artery disease	4.29e-06	3.76e-05	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—PIK3CA—coronary artery disease	4.26e-06	3.73e-05	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—IL6—coronary artery disease	4.23e-06	3.7e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—IGF1—coronary artery disease	4.23e-06	3.7e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—MAPK1—coronary artery disease	4.21e-06	3.69e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—CTGF—coronary artery disease	4.19e-06	3.67e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—HMGCR—coronary artery disease	4.16e-06	3.64e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—GOT2—coronary artery disease	4.16e-06	3.64e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—GSTM2—coronary artery disease	4.07e-06	3.56e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—PLIN1—coronary artery disease	4.07e-06	3.56e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—PFKFB3—coronary artery disease	4.07e-06	3.56e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—COX5B—coronary artery disease	4.07e-06	3.56e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—DLAT—coronary artery disease	4.07e-06	3.56e-05	CbGpPWpGaD
Vardenafil—PDE1B—GPCR downstream signaling—PIK3CA—coronary artery disease	4.02e-06	3.52e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—SERPINE1—coronary artery disease	4.02e-06	3.52e-05	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—AKT1—coronary artery disease	3.9e-06	3.42e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—FGF2—coronary artery disease	3.89e-06	3.4e-05	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—IL6—coronary artery disease	3.87e-06	3.39e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—SULT1E1—coronary artery disease	3.86e-06	3.38e-05	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—MAPK1—coronary artery disease	3.84e-06	3.37e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—NOS3—coronary artery disease	3.83e-06	3.36e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—PLCB1—coronary artery disease	3.82e-06	3.35e-05	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—IL6—coronary artery disease	3.77e-06	3.3e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—JAK2—coronary artery disease	3.73e-06	3.26e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—ABCA1—coronary artery disease	3.7e-06	3.24e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—HK2—coronary artery disease	3.68e-06	3.22e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—AKR1B1—coronary artery disease	3.68e-06	3.22e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—PIK3CA—coronary artery disease	3.65e-06	3.2e-05	CbGpPWpGaD
Vardenafil—PDE1B—Disease—TGFB1—coronary artery disease	3.62e-06	3.17e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—GOT1—coronary artery disease	3.59e-06	3.14e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—GGT1—coronary artery disease	3.59e-06	3.14e-05	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—AKT1—coronary artery disease	3.57e-06	3.13e-05	CbGpPWpGaD
Vardenafil—PDE1B—Disease—MAPK1—coronary artery disease	3.55e-06	3.11e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—SLC27A1—coronary artery disease	3.53e-06	3.09e-05	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—AKT1—coronary artery disease	3.48e-06	3.05e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—CPT1B—coronary artery disease	3.46e-06	3.03e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—LCAT—coronary artery disease	3.46e-06	3.03e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—CXCL8—coronary artery disease	3.4e-06	2.98e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—APOA4—coronary artery disease	3.39e-06	2.97e-05	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—PIK3CA—coronary artery disease	3.34e-06	2.92e-05	CbGpPWpGaD
Vardenafil—PDE1B—GPCR downstream signaling—AKT1—coronary artery disease	3.28e-06	2.88e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—GCLM—coronary artery disease	3.28e-06	2.87e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—PDHA1—coronary artery disease	3.28e-06	2.87e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—CASP3—coronary artery disease	3.25e-06	2.85e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—IL6—coronary artery disease	3.23e-06	2.83e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—GSTP1—coronary artery disease	3.22e-06	2.82e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—PPARGC1A—coronary artery disease	3.19e-06	2.8e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—HMOX1—coronary artery disease	3.18e-06	2.78e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—CYP11B2—coronary artery disease	3.18e-06	2.78e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—TXNRD1—coronary artery disease	3.18e-06	2.78e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—CCND1—coronary artery disease	3.17e-06	2.77e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—CAT—coronary artery disease	3.14e-06	2.75e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—SLC22A3—coronary artery disease	3.13e-06	2.74e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—ARNTL—coronary artery disease	3.08e-06	2.7e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—HADH—coronary artery disease	3.08e-06	2.7e-05	CbGpPWpGaD
Vardenafil—PDE1B—Disease—PIK3CA—coronary artery disease	3.08e-06	2.7e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—MMP9—coronary artery disease	3.08e-06	2.69e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—APOB—coronary artery disease	3.04e-06	2.67e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—AKT1—coronary artery disease	2.98e-06	2.61e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—GSTM1—coronary artery disease	2.96e-06	2.59e-05	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—IL6—coronary artery disease	2.95e-06	2.59e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—APOA2—coronary artery disease	2.92e-06	2.56e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—GPX2—coronary artery disease	2.92e-06	2.56e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—PLA2G2A—coronary artery disease	2.92e-06	2.56e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—LPL—coronary artery disease	2.91e-06	2.55e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—GPX4—coronary artery disease	2.89e-06	2.53e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—ABCG5—coronary artery disease	2.89e-06	2.53e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—HK1—coronary artery disease	2.89e-06	2.53e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—SULT1A1—coronary artery disease	2.89e-06	2.53e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—HADHA—coronary artery disease	2.85e-06	2.5e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—GPX1—coronary artery disease	2.84e-06	2.48e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—GSTA1—coronary artery disease	2.82e-06	2.47e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—LPA—coronary artery disease	2.79e-06	2.44e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—CD36—coronary artery disease	2.76e-06	2.42e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—VEGFA—coronary artery disease	2.76e-06	2.42e-05	CbGpPWpGaD
Vardenafil—PDE1B—Disease—IL6—coronary artery disease	2.73e-06	2.39e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—PPP2CA—coronary artery disease	2.73e-06	2.39e-05	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—AKT1—coronary artery disease	2.73e-06	2.39e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—PLCB3—coronary artery disease	2.7e-06	2.36e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—APOA5—coronary artery disease	2.67e-06	2.34e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—P4HB—coronary artery disease	2.62e-06	2.3e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—MTHFR—coronary artery disease	2.62e-06	2.29e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—PLA2G1B—coronary artery disease	2.57e-06	2.25e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—TGFB1—coronary artery disease	2.53e-06	2.22e-05	CbGpPWpGaD
Vardenafil—PDE1B—Disease—AKT1—coronary artery disease	2.52e-06	2.2e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—AGT—coronary artery disease	2.49e-06	2.18e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—MAPK1—coronary artery disease	2.49e-06	2.18e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—APOE—coronary artery disease	2.44e-06	2.13e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—VCAN—coronary artery disease	2.43e-06	2.12e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—APOA1—coronary artery disease	2.41e-06	2.11e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—ALDOA—coronary artery disease	2.41e-06	2.11e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—DCN—coronary artery disease	2.34e-06	2.05e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—ALDH2—coronary artery disease	2.27e-06	1.99e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—LIPC—coronary artery disease	2.21e-06	1.94e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—HBA1—coronary artery disease	2.21e-06	1.94e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—PIK3C2A—coronary artery disease	2.21e-06	1.94e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—CYP2C19—coronary artery disease	2.21e-06	1.94e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—APOC3—coronary artery disease	2.2e-06	1.93e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—LDLR—coronary artery disease	2.19e-06	1.92e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—SLC9A1—coronary artery disease	2.16e-06	1.89e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—GSTT1—coronary artery disease	2.16e-06	1.89e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—PIK3CA—coronary artery disease	2.16e-06	1.89e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—GCLC—coronary artery disease	2.14e-06	1.87e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—CETP—coronary artery disease	2.14e-06	1.87e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—PPARG—coronary artery disease	2.12e-06	1.86e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—SDC1—coronary artery disease	2.11e-06	1.85e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—POMC—coronary artery disease	2.09e-06	1.83e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—PSMA6—coronary artery disease	2e-06	1.75e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—PSMB5—coronary artery disease	2e-06	1.75e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—CTGF—coronary artery disease	1.95e-06	1.71e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—HMGCR—coronary artery disease	1.93e-06	1.69e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—GOT2—coronary artery disease	1.93e-06	1.69e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—IL6—coronary artery disease	1.91e-06	1.67e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—ALB—coronary artery disease	1.91e-06	1.67e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—NOS3—coronary artery disease	1.83e-06	1.6e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—PLCB1—coronary artery disease	1.78e-06	1.56e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—AKT1—coronary artery disease	1.76e-06	1.54e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—ABCA1—coronary artery disease	1.72e-06	1.51e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—PTGS2—coronary artery disease	1.67e-06	1.46e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—GOT1—coronary artery disease	1.67e-06	1.46e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—GGT1—coronary artery disease	1.67e-06	1.46e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—GSTP1—coronary artery disease	1.5e-06	1.31e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—PPARGC1A—coronary artery disease	1.48e-06	1.3e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—HMOX1—coronary artery disease	1.48e-06	1.29e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—CAT—coronary artery disease	1.46e-06	1.28e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—APOB—coronary artery disease	1.42e-06	1.24e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—GSTM1—coronary artery disease	1.38e-06	1.21e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—LPL—coronary artery disease	1.35e-06	1.18e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—GPX1—coronary artery disease	1.32e-06	1.15e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—CD36—coronary artery disease	1.28e-06	1.12e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—PPP2CA—coronary artery disease	1.27e-06	1.11e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—MTHFR—coronary artery disease	1.22e-06	1.07e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—AGT—coronary artery disease	1.16e-06	1.01e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—APOE—coronary artery disease	1.13e-06	9.92e-06	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—APOA1—coronary artery disease	1.12e-06	9.81e-06	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—PIK3CA—coronary artery disease	1.03e-06	9e-06	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—PPARG—coronary artery disease	9.87e-07	8.64e-06	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—POMC—coronary artery disease	9.73e-07	8.52e-06	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—ALB—coronary artery disease	8.87e-07	7.77e-06	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—NOS3—coronary artery disease	8.49e-07	7.43e-06	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—AKT1—coronary artery disease	8.39e-07	7.35e-06	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—PTGS2—coronary artery disease	7.76e-07	6.8e-06	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—PIK3CA—coronary artery disease	4.78e-07	4.18e-06	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—AKT1—coronary artery disease	3.9e-07	3.42e-06	CbGpPWpGaD
